Historical record - last NADAC effective date: 10/19/2016
Product Information
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0449 per EA under NDC 65862004505. Its NADAC has been published 156 times since Nov 28, 2013.
FDA first approved this application on Mar 14, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Lisinopril and Hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25; 20 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862004505
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
10/19/2016
Active Ingredients
HYDROCHLOROTHIAZIDE; LISINOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077606FDA Approved
3/14/2006
TE Code
AB
On Market Since
3/14/2006
Pharmacological Classes
Price Statistics
The NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has been published 156 times since Nov 28, 2013, and over the history we have for it it has declined 8.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0449 per EA |
|---|---|
| All-time high | $0.0548 (Apr 16, 2014) |
| All-time low | $0.0406 (Jun 22, 2016) |
| Median price | $0.0468 |
| Average price | $0.0471 |
| Largest weekly change | -13.0% (Aug 19, 2015) |
| Weeks tracked | 156 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-8.9%
Last surveyed Nov 16, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.0449 per EA (NDC 65862004505), effective Nov 16, 2016.
How has the price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB changed over time?
Over the history we have for it, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has declined 8.9%. It has been tracked across 156 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?
Since Nov 28, 2013, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB has ranged from a low of $0.0406 (Jun 22, 2016) to a high of $0.0548 (Apr 16, 2014), with a median of $0.0468 per EA.
Are there cheaper alternatives to LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB, is $0.0405 per EA — about 10% below LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB.
Who manufactures LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB?
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-25 MG TAB (NDC 65862004505) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.